Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Coya Therapeutics (COYA) Total Liabilities (2022 - 2025)

Coya Therapeutics' Total Liabilities history spans 4 years, with the latest figure at $4.8 million for Q3 2025.

  • For Q3 2025, Total Liabilities rose 34.36% year-over-year to $4.8 million; the TTM value through Sep 2025 reached $4.8 million, up 34.36%, while the annual FY2024 figure was $4.8 million, 15.23% down from the prior year.
  • Total Liabilities for Q3 2025 was $4.8 million at Coya Therapeutics, down from $5.1 million in the prior quarter.
  • Across five years, Total Liabilities topped out at $16.8 million in Q4 2022 and bottomed at -$2.0 million in Q1 2022.
  • The 4-year median for Total Liabilities is $4.8 million (2025), against an average of $4.3 million.
  • The largest annual shift saw Total Liabilities plummeted 66.49% in 2023 before it soared 294.84% in 2024.
  • A 4-year view of Total Liabilities shows it stood at $16.8 million in 2022, then tumbled by 66.49% to $5.6 million in 2023, then fell by 15.23% to $4.8 million in 2024, then fell by 0.24% to $4.8 million in 2025.
  • Per Business Quant, the three most recent readings for COYA's Total Liabilities are $4.8 million (Q3 2025), $5.1 million (Q2 2025), and $5.0 million (Q1 2025).